Exploring the role of serum adiponectin and its holigomerization in fibrotic interstitial lung diseases: results from a cross-sectional study
Abstract Intestitial lung diseases (ILDs) include a group of inflammatory and fibrotic pulmonary disorders with different etiologies which in several patients might lead to a progressive reduction of respiratory capacities and chronic respiratory failure. Nowadays, biomarkers for predicting the ILD...
Saved in:
| Main Authors: | Ersilia Nigro, Vito D’Agnano, Raffaella Pagliaro, Marta Mallardo, Andrea Bianco, Carmine Picone, Adolfo Gallipoli D’Errico, Aurora Daniele, Fabio Perrotta |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-05-01
|
| Series: | BMC Pulmonary Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12890-025-03706-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Obesity and breast cancer: Association of serum adiponectin, leptin, and adiponectin–leptin ratio as risk biomarkers
by: Madhav Danthala, et al.
Published: (2018-01-01) -
ADIPONECTIN AND ATHEROSCLEROTIC REMODELLING OF CAROTID ARTERIES
by: O. P. Shevchenko, et al.
Published: (2011-08-01) -
Plasma Concentrations of Adiponectin in Patients with Coronary Artery Disease and Coronary Slow Flow
by: Muhammad Diah, et al.
Published: (2020-02-01) -
Plasma Concentrations of Adiponectin in Patients with Coronary Artery Disease and Coronary Slow Flow
by: Muhammad Diah, et al.
Published: (2020-02-01) -
The significance of adiponectin as a biomarker in metabolic syndrome and/or coronary artery disease
by: Stojanović Sanja, et al.
Published: (2015-01-01)